Severe cytopenia (ANC <0.5 OR platelets <50 OR Hgb <8) at diagnosis — disease-driven marr...
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | RF-T-PLL-ORGAN-DYSFUNCTION |
|---|---|
| Type | Red flag |
| Status | reviewed 2026-04-25 | pending_clinical_signoff |
| Diseases | DIS-T-PLL |
| Sources | SRC-ESMO-PTCL-2024 SRC-NCCN-BCELL-2025 |
Red Flag Origin
| Definition | Severe cytopenia (ANC <0.5 OR platelets <50 OR Hgb <8) at diagnosis — disease-driven marrow infiltration; alemtuzumab will worsen lymphopenia; growth-factor support + transfusion threshold management critical. |
|---|---|
| Clinical direction | investigate |
| Category | organ-dysfunction |
Trigger Logic
{
"any_of": [
{
"comparator": "<",
"finding": "anc_x10_9_l",
"threshold": 0.5
},
{
"comparator": "<",
"finding": "platelets_x10_9_l",
"threshold": 50
},
{
"comparator": "<",
"finding": "hemoglobin_g_dl",
"threshold": 8
}
],
"type": "lab_value"
}
Notes
T-PLL cytopenias are disease-driven; alemtuzumab causes profound CD52+ lymphocyte depletion (months). Supportive care + opportunistic infection prophylaxis essential.
Used By
No reverse references found in the YAML corpus.